Concerns and precautions for a patient living with chronic fibrosing ILD with progressive phenotype during the coronavirus pandemic.
Concerns and precautions for a patient living with chronic fibrosing ILD with progressive phenotype during the coronavirus pandemic.
Transcript:
Dawn Repola: On my own at home, I have a pulse oximeter that I use whenever I’m feeling like my oxygen might be low. That’s what I do personally, and of course I have my oxygen that I use. For the monitoring that is done for me at the clinic, I go in every 3 months. I have blood monitoring that happens on a monthly basis. I go in every 3 months, and I have pulmonary function tests each time I go in. Every 6 months I have a 6-minute walk test, and I have a high-risk CT [computed tomography] scan once a year. That’s the close look to see if there’s been progression.
COVID-19 [coronavirus disease 2019] for me is scary. Quite frankly, I’m terrified. I think it’s because there’s a lack of information, because this is something we’ve never experienced before, so we don’t have any good information. I tend to err on the side of caution. The precaution I’m taking is I’m a world champion at social distancing. Once I got the lesson around how immunosuppression means that you have to stay away from large crowds and sick people, and cold and flu season means you need to hang out at your home and be careful who you’re around and avoid situations where you might be exposed, social distancing for COVID-19 wasn’t that big of a deal for me.
For my friends who are extroverts, it was a big deal. But I was like, “Yeah, I live on Zoom anyway.” I communicate well outside that, so that wasn’t all that different. The thing that was different was having my husband do all the grocery shopping. I’m the cook, so that means I get some interesting ingredients that I have to deal with. It’s difficult to not be able to just go out to the store if you need to go out to get something. I don’t see that my life is that different in preparing and defending against COVID-19. I’m really looking forward to the time when we have good, reliable testing and good, reliable immunizations for the disease.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More